Sen. John McCain: Obamacare is 'Collapsing' After

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
Sen. John McCain: Obamacare is 'Collapsing'

After reporting a $200 million loss tied to the Affordable Care Act, Aetna (AET) became the latest of the nation’s largest insurers to declare a severe cut back on its exchange business. This follows similar moves by UnitedHealth (UNH) and Humana (HUM), both companies also citing the financial burden of Obamacare.

In 2017, Aetna is expected to offer plans on exchanges in only four states, Humana in 11 or less, and UnitedHealth in 12.

Even one of the bill’s architects won’t deny the exchanges are deteriorating: “I think we clearly need to work with, and find out what would be helpful to, insurers. Exchanges don’t naturally work. How do we know that? We’ve had exchanges before… They often do collapse if you get adverse selection in them… And, let’s face it, we’ve got to get more people enrolled,” Emanuel says.

As of March 2016, only 11.1 million people were enrolled in the exchanges, well below the Congressional Budget Office’s initial estimate of 21 million.

The difficulty precluding solutions to these problems is the deep-rooted partisanship that has beleaguered the law since inception.

As a sitting member of the Senate during the passage of the Affordable Care Act, McCain’s memory of the vote is not a fond one: “It’s the first entitlement program ever passed on a strictly party-line basis. There were no amendments allowed to be voted on... It was a 60 vote majority in the Senate, overwhelming majority in the House, and they just rode roughshod over the Republicans.” With a filibuster-proof majority of 60 in the Senate, the Democrats didn’t need one Republican Senator to approve the bill. And they didn’t get one.

“It was a total failure to outreach to any Republicans... Frankly, it was arrogance,” McCain laments.

Like many others on his side of the aisle, McCain is in favor of scrapping the health care bill altogether. “Ideally I’d like to go back to square one. Provide for a free market, capitalistic approach to it.” He proposes risk pools, interstate policy availability, improving the way generic drugs are put on the market, expanding the reach of community health centers and giving people the choice to opt out of health care altogether, as potential policy solutions.

Emanuel doesn’t view scrapping the bill as an option. “We need to work within the framework we have here. This idea of replacing makes sense only if you’ve got a replacement, there’s no replacement here… And we’re not going to get a replacement by the way. I don’t think there’s another alternative that makes sense,” Emanuel says. The former White House adviser calls high risk pools a “terrible idea” and believes the proposed plan put forth by House Speaker Paul Ryan (R-WI) “isn’t coherent.”

Emanuel’s reform bids include a better marketing campaign, renovating the website, bringing more awareness to the individual mandate penalty, and decreasing price inflation.

To Emanuel, the Affordable Care Act is a work in progress, but one that can’t be amended until the Republicans get on board. “We’ve had people praying for its failure, working to make it fail, claiming it’s terrible, and then saying ‘you know, you didn’t make it work.’ Well, reforms couldn’t be introduced, changes couldn’t be made, and flexibility was denied at every turn.”

Despite their vast ideological differences, McCain and Emanuel do agree on one thing. The distastefulness of the public option: a proposal to create a government-run insurance provider, which is part of Hillary Clinton’s healthcare platform.

“It’s like throwing gasoline on the fire,” chides McCain.

Emanuel agrees it’s not the best recourse, but it might be the only option if the government can’t incentivize private insurers to remain on the exchanges. “If you can’t get insurers in certain places it may be the thing you need to do. I don’t think it’s anyone’s, and I don’t even think it’s [Hillary Clinton’s] first option.”

The troubling reality is that it doesn’t matter how many insurers pull out of the exchanges or how high premiums rise. No valuable changes will be made to improve the Affordable Care Act if Washington cannot agree on more than just the undesirable nature of the public option.

“This is a political gridlock issue. There are things that have built up that need to be done and… I hope the Republicans can now see that it’s in their interest to work with the democrats on making sensible revisions,” says Emanuel.

But for now, there’s at least one Republican Senator who is content with watching America question the effectiveness of the Obama Administration’s most highly touted accomplishment. “The whole thing is unraveling as many of us predicted it would.”

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 154

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 136

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 154

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 27

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 129

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 150

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading

Top 5 Most Recently Viewed Articles

Coca-Cola's Emerging Markets Strategy Fuels Long-Term Growth

Updated Category News Views 929

Coca-Cola's Position in Emerging Markets Coca-Cola Co (NYSE: KO) stands as a beacon of growth, with a visionary strategy that highlights both immediate and long-term opportunities. The company has successfully positioned itself in vital markets, particularly in North America and Latin America, which have proven central to its success. According to recent insights from...

Continue Reading
Voda IQ Appoints Armando Piccinini to Drive European Sales

Updated Category News Views 121

Voda IQ dropped some big news back in 2024 when they appointed Armando Piccinini as their European Sales Director. This guy’s got over twenty years under his belt in aquatic conservation, which they clearly hope will ramp up their sales strategy across Europe. But you gotta wonder—are the numbers behind this move really there? Can Experience Translate to Sales Growth?...

Continue Reading
Magnera Corporation to Shine at Upcoming Finance Conference

Updated Category News Views 163

Magnera Corporation's Conference Participation Announcement Magnera Corporation (NYSE: MAGN) has made an exciting announcement regarding its upcoming participation in a significant financial event. The company is set to be a part of the 2025 Bank of America Leveraged Finance Conference, aimed at fostering connections with top institutional investors. The event will take...

Continue Reading
Bullish Momentum Unveiled: Insights on Merck & Co Stocks

Updated Category News Views 180

Exciting Developments in Merck & Co Options Activity Notable investors are expressing strong optimism about Merck & Co. A recent analysis of options trading strategies reveals a wave of activity among traders aiming to capitalize on this potential. Options Trading Overview When reviewing the options history for Merck & Co (NYSE: MRK), we found a total of 33 trades that...

Continue Reading
Gilead Snags Arcellx: A High-Stakes Cancer Gamble Unfolds

Updated Category News Views 195

The Big Play for Cancer Innovation Gilead Sciences Inc. (NASDAQ:GILD) pulled the trigger on a pretty huge acquisition deal, landing Arcellx Inc. (NASDAQ:ACLX) this past Monday for a staggering $115 per share, which gets better with a potential extra $5 per share on a contingent value right. That rings in a hefty total of $7.8 billion—no pocket change, folks. What’s...

Continue Reading